Eli Lilly raises the revenue forecast on sales of weight loss drugs, cuts the profit view on transaction charges.
Eli Lilly raises the revenue forecast on sales of weight loss drugs, cuts the profit view on transaction charges.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in